Quarterly results
Discover our latest financial performance announcement and search for historical quarterly results materials dating back to 2010.
Latest results
Emma Walmsley, CEO, GSK, announces our Q2 2022 results
2022 Second quarter 27 July 2022
We announced our second quarter 2022 results on Wednesday 27 July.
Join the live webcast today with Emma Walmsley, CEO, and other members of her team at 12:00 BST, 07:00 EDT.
Highlights
Downloads
- Q2 2022 results announcement (PDF - 1.5MB)
- Q2 2022 results slides (PDF - 4.7MB)
- Q2 2022 results transcript (PDF - 477.6KB)
- Q2 2022 clinical trials summary (PDF - 999.2KB)
- Q2 2022 results infographic (PDF - 87.4KB)
- Q2 2022 US dollar translation (PDF - 333.2KB)
- 2022 Q2 pre announcement aide memoire (PDF - 400.2KB)
- GSK to disclose discontinued operations from Q2 2022 (PDF - 125.4KB)
-
2013 First Quarter 24 April 2013
Simon Dingemans, CFO, discusses our first quarter results 2013.
Related downloads
-
2012 Fourth Quarter 06 February 2013
Simon Dingemans, CFO, and Sir Andrew Witty, CEO, discuss our fourth quarter results 2012.
Key highlights
- Core EPS of 112.7p and returns of £6.3bn to shareholders
- 2012 dividend of 74p (+6%)
- Group sales -1%; flat excluding disposals of OTC brands
- Successful R&D delivery: six new drugs filed since start of 2012
Related downloads
- Q4 2012 results announcement (PDF - 286.3KB)
- Q4 2012 results analyst presentation colour (PDF - 408.1KB)
- Q4 2012 analyst presentation bandw (PDF - 351.1KB)
- Q4 2012 analyst presentation transcript (PDF - 68.1KB)
- Q4 2012 actual growth schedules (PDF - 35.3KB)
- Q4 2012 US dollar translation (PDF - 31.8KB)
-
2012 Third Quarter 31 October 2012
Simon Dingemans, CFO, discusses our Q3 results 2012.
Key highlights
- Core EPS of 26.5p
- Dividend of 18p (+ 6%)
- Further successful R&D delivery: phase III programmes completed for 6 novel medicines in 2012
- Continued strong cash generation and returns to shareholders
-
2012 Second Quarter 25 July 2012
Watch Sir Andrew Witty, CEO, discuss our second quarter results 2012.
Key highlights
- Core EPS of 26.4p
- Dividend of 17p (up 6%)
- Significant late-stage pipeline delivery
